Lindenwold Advisors INC Sells 1,198 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Lindenwold Advisors INC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.5% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 7,709 shares of the healthcare conglomerate’s stock after selling 1,198 shares during the period. UnitedHealth Group comprises about 2.1% of Lindenwold Advisors INC’s investment portfolio, making the stock its 13th largest holding. Lindenwold Advisors INC’s holdings in UnitedHealth Group were worth $3,900,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of UNH. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. Promus Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth $32,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group during the 3rd quarter worth $37,000. Finally, Pillar Financial Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on UNH shares. Truist Financial lowered their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Oppenheimer lifted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Trading Up 0.9 %

UnitedHealth Group stock opened at $503.61 on Wednesday. The firm has a 50-day moving average of $510.90 and a 200-day moving average of $548.54. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market cap of $460.66 billion, a price-to-earnings ratio of 32.49, a P/E/G ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the business posted $5.83 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.67%. UnitedHealth Group’s payout ratio is 54.19%.

Insider Activity

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. 0.33% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.